Consolidated Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total		Cumulative Effect, Period of Adoption, Adjustment	Total NantHealth Stockholders' Deficit	Total NantHealth Stockholders' Deficit Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2019						110,619,678
Beginning balance at Dec. 31, 2019	$ (57,136)			$ (57,136)		$ 11	$ 889,955		$ (946,884)		$ (218)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	2,725			2,725			2,725
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes ( in shares)						665,055
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes	(568)			(568)			(568)
Assignment of OpenNMS	(26)			(529)			(529)					503
Other comprehensive loss	51			50							50	1
Net loss	(56,446)	[1]		(56,326)					(56,326)			(120)
Ending balance (in shares) at Dec. 31, 2020						111,284,733
Ending balance at Dec. 31, 2020	$ (111,400)		$ (5,746)	(111,784)	$ (5,746)	$ 11	891,583	$ (14,318)	(1,003,210)	$ 8,572	(168)	384
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 Retrospective [Member]
Stock-based compensation expense	$ 4,005			4,005			4,005
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes ( in shares)						604,541
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes	291			291			291
Stock issued on Exchange of 2016 Notes (in shares)						3,615,970
Stock issued on Exchange of 2016 Notes	10,001			10,001		$ 1	10,000
Purchase of noncontrolling interest	(556)			(456)			(456)					(100)
Other comprehensive loss	(44)			(44)							(44)
Net loss	(58,543)			(58,259)					(58,259)			(284)
Ending balance (in shares) at Dec. 31, 2021						115,505,244
Ending balance at Dec. 31, 2021	$ (161,992)			$ (161,992)		$ 12	$ 891,105		$ (1,052,897)		$ (212)	$ 0

[1] The statements for the year ended December 31, 2020 includes the Connected Care Business (see Note 4).